Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Long-term adverse events after sleeve gastrectomy or gastric bypass: a 7-year nationwide, observational, population-based, cohort study.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Lancet Diabetes Endocrinol. 2019 Oct;7(10):786-795. doi: 10.1016/S2213-8587(19)30191-3. Epub 2019 Aug 2.

PMID:
31383618
3.

Multicentre cohort study of antihypertensive and lipid-lowering therapy cessation after bariatric surgery.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Br J Surg. 2019 Feb;106(3):286-295. doi: 10.1002/bjs.10999. Epub 2018 Oct 16.

PMID:
30325504
4.

Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

JAMA Surg. 2018 Jun 1;153(6):526-533. doi: 10.1001/jamasurg.2017.6163.

5.

Long-term follow-up after bariatric surgery in a national cohort.

Thereaux J, Lesuffleur T, Païta M, Czernichow S, Basdevant A, Msika S, Millat B, Fagot-Campagna A.

Br J Surg. 2017 Sep;104(10):1362-1371. doi: 10.1002/bjs.10557. Epub 2017 Jun 28.

PMID:
28657109
6.

To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Ann Surg. 2018 Apr;267(4):727-733. doi: 10.1097/SLA.0000000000002285.

PMID:
28475558
7.

Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort.

Thereaux J, Lesuffleur T, Czernichow S, Basdevant A, Msika S, Nocca D, Millat B, Fagot-Campagna A.

Surg Obes Relat Dis. 2017 Jun;13(6):951-959. doi: 10.1016/j.soard.2016.12.013. Epub 2016 Dec 23.

PMID:
28223087
8.

Current challenges in providing bariatric surgery in France: A nationwide study.

Czernichow S, Paita M, Nocca D, Msika S, Basdevant A, Millat B, Fagot-Campagna A.

Medicine (Baltimore). 2016 Dec;95(49):e5314. Erratum in: Medicine (Baltimore). 2017 Mar 24;96(12):e6510.

9.

Obesity Management in Europe: Current Status and Objectives for the Future.

Uerlich MF, Yumuk V, Finer N, Basdevant A, Visscher TL.

Obes Facts. 2016;9(4):273-83. doi: 10.1159/000445192. Epub 2016 Aug 20.

10.

[Bariatric surgery in teenagers].

Basdevant A.

Rev Prat. 2015 Jun;65(6):760-2. French.

PMID:
26298894
11.

[Pregnancy and bariatric surgery: Critical points].

Ciangura C, Nizard J, Poitou-Bernert C, Dommergues M, Oppert JM, Basdevant A.

J Gynecol Obstet Biol Reprod (Paris). 2015 Jun;44(6):496-502. doi: 10.1016/j.jgyn.2015.01.010. Epub 2015 Feb 25. Review. French.

12.

Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey.

Eschwege E, Basdevant A, Crine A, Moisan C, Charles MA.

Diabetes Metab. 2015 Feb;41(1):55-61. doi: 10.1016/j.diabet.2014.11.007. Epub 2014 Dec 24.

PMID:
25544682
13.

[What about a new job in the health system: The coordinator of care].

Meininger V, Fontaine B, Grabli D, Basdevant A, Clement K, Vignot M, Cordesse V.

Presse Med. 2014 Oct;43(10 Pt 1):1031-3. doi: 10.1016/j.lpm.2014.06.006. Epub 2014 Jul 26. French. No abstract available.

PMID:
25073809
14.

Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients.

Gesquiere I, Aron-Wisnewsky J, Foulon V, Haggege S, Van der Schueren B, Augustijns P, Bouillot JL, Clement K, Basdevant A, Oppert JM, Buyse M.

Obes Surg. 2014 Nov;24(11):1896-903. doi: 10.1007/s11695-014-1325-8.

PMID:
24947346
15.

ZHENG May Contribute to Obesity Phenotypes Based on Body Composition: A Pilot Study on the Traditional Chinese Medicine Approach.

Tao F, Lu H, Oppert JM, Basdevant A.

Evid Based Complement Alternat Med. 2014;2014:580803. doi: 10.1155/2014/580803. Epub 2014 Mar 10.

16.

Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes.

Kong LC, Tap J, Aron-Wisnewsky J, Pelloux V, Basdevant A, Bouillot JL, Zucker JD, Doré J, Clément K.

Am J Clin Nutr. 2013 Jul;98(1):16-24. doi: 10.3945/ajcn.113.058743. Epub 2013 May 29.

PMID:
23719559
17.

Pharmacokinetics of immunomodulator treatments after roux-en-y bypass in obese patient.

Aron-Wisnewsky J, Lemaitre F, Clément K, Bouillot JL, Fernandez C, Basdevant A, Oppert JM, Buyse M.

J Clin Pharmacol. 2013 Jul;53(7):779-84. doi: 10.1002/jcph.99. Epub 2013 May 14. No abstract available.

PMID:
23670812
18.

Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity.

Lloret-Linares C, Faucher P, Coupaye M, Alili R, Green A, Basdevant A, Clément K, Poitou C.

Int J Obes (Lond). 2013 Sep;37(9):1198-203. doi: 10.1038/ijo.2012.228. Epub 2013 Jan 15.

PMID:
23318724
19.

Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbidities.

Julia C, Ciangura C, Capuron L, Bouillot JL, Basdevant A, Poitou C, Oppert JM.

Diabetes Metab. 2013 Apr;39(2):148-54. doi: 10.1016/j.diabet.2012.10.008. Epub 2013 Jan 10.

PMID:
23313223
20.

Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.

Coupaye M, Lorenzini F, Lloret-Linares C, Molinas C, Pinto G, Diene G, Mimoun E, Demeer G, Labrousse F, Jauregi J, Laurier V, Basdevant A, Polak M, Thuilleaux D, Tauber M, Poitou C.

J Clin Endocrinol Metab. 2013 Feb;98(2):E328-35. doi: 10.1210/jc.2012-2881. Epub 2013 Jan 2.

PMID:
23284006
21.

Homozygous leptin receptor mutation due to uniparental disomy of chromosome 1: response to bariatric surgery.

Le Beyec J, Cugnet-Anceau C, Pépin D, Alili R, Cotillard A, Lacorte JM, Basdevant A, Laville M, Clément K.

J Clin Endocrinol Metab. 2013 Feb;98(2):E397-402. doi: 10.1210/jc.2012-2779. Epub 2012 Dec 28.

PMID:
23275530
22.

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.

Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, Tordjman J, Clement K.

Hepatology. 2012 Nov;56(5):1751-9. doi: 10.1002/hep.25889.

PMID:
22707395
23.

Dynamic relations between sedentary behavior, physical activity, and body composition after bariatric surgery.

Vatier C, Henegar C, Ciangura C, Poitou-Bernert C, Bouillot JL, Basdevant A, Oppert JM.

Obes Surg. 2012 Aug;22(8):1251-6. doi: 10.1007/s11695-012-0619-y.

PMID:
22351039
24.

Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity.

Tordjman J, Divoux A, Prifti E, Poitou C, Pelloux V, Hugol D, Basdevant A, Bouillot JL, Chevallier JM, Bedossa P, Guerre-Millo M, Clement K.

J Hepatol. 2012 May;56(5):1152-8. doi: 10.1016/j.jhep.2011.12.015. Epub 2012 Jan 13.

PMID:
22245892
25.

Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports.

Ciangura C, Corigliano N, Basdevant A, Mouly S, Declèves X, Touraine P, Lloret-Linares C.

Contraception. 2011 Dec;84(6):649-51. doi: 10.1016/j.contraception.2011.03.015. Epub 2011 May 8.

PMID:
22078197
26.

Criteria for EASO-collaborating centres for obesity management.

Tsigos C, Hainer V, Basdevant A, Finer N, Mathus-Vliegen E, Micic D, Maislos M, Roman G, Schutz Y, Toplak H, Yumuk V, Zahorska-Markiewicz B; Obesity Management Task Force of the European Association for the Study of Obesity.

Obes Facts. 2011;4(4):329-33. doi: 10.1159/000331236. Epub 2011 Aug 11.

27.

Effect of dental status on changes in mastication in patients with obesity following bariatric surgery.

Godlewski AE, Veyrune JL, Nicolas E, Ciangura CA, Chaussain CC, Czernichow S, Basdevant A, Hennequin M.

PLoS One. 2011;6(7):e22324. doi: 10.1371/journal.pone.0022324. Epub 2011 Jul 20.

28.

Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.

Aron-Wisnewsky J, Minville C, Tordjman J, Lévy P, Bouillot JL, Basdevant A, Bedossa P, Clément K, Pépin JL.

J Hepatol. 2012 Jan;56(1):225-33. doi: 10.1016/j.jhep.2011.04.022. Epub 2011 May 19.

PMID:
21703181
29.

Urokinase plasminogen activator receptor in adipose tissue macrophages of morbidly obese subjects.

Cancello R, Rouault C, Guilhem G, Bedel JF, Poitou C, Di Blasio AM, Basdevant A, Tordjman J, Clément K.

Obes Facts. 2011;4(1):17-25. doi: 10.1159/000324587. Epub 2011 Feb 16.

30.

Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women.

Aron-Wisnewsky J, Julia Z, Poitou C, Bouillot JL, Basdevant A, Chapman MJ, Clement K, Guerin M.

J Clin Endocrinol Metab. 2011 Apr;96(4):1151-9. doi: 10.1210/jc.2010-2378. Epub 2011 Feb 2.

PMID:
21289254
31.

Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss.

Kim MJ, Marchand P, Henegar C, Antignac JP, Alili R, Poitou C, Bouillot JL, Basdevant A, Le Bizec B, Barouki R, Clément K.

Environ Health Perspect. 2011 Mar;119(3):377-83. doi: 10.1289/ehp.1002848. Epub 2010 Dec 15.

32.

Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis.

Richette P, Poitou C, Garnero P, Vicaut E, Bouillot JL, Lacorte JM, Basdevant A, Clément K, Bardin T, Chevalier X.

Ann Rheum Dis. 2011 Jan;70(1):139-44. doi: 10.1136/ard.2010.134015. Epub 2010 Oct 26.

PMID:
20980288
33.

Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation.

Capuron L, Poitou C, Machaux-Tholliez D, Frochot V, Bouillot JL, Basdevant A, Layé S, Clément K.

Psychol Med. 2011 Jul;41(7):1517-28. doi: 10.1017/S0033291710001984. Epub 2010 Oct 20.

PMID:
20961476
34.

Validity of leg-to-leg bioelectrical impedance analysis to estimate body fat in obesity.

Lloret Linares C, Ciangura C, Bouillot JL, Coupaye M, Declèves X, Poitou C, Basdevant A, Oppert JM.

Obes Surg. 2011 Jul;21(7):917-23. doi: 10.1007/s11695-010-0296-7.

PMID:
20936394
35.

Who is considered obese? Why? Clinical and therapeutic implications.

Ciangura C, Touizer E, Basdevant A.

J Visc Surg. 2010 Oct;147(5 Suppl):e5-9. doi: 10.1016/j.jviscsurg.2010.08.012. Epub 2010 Sep 28. No abstract available.

PMID:
20880769
36.

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.

Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, Mariat D, Corthier G, Doré J, Henegar C, Rizkalla S, Clément K.

Diabetes. 2010 Dec;59(12):3049-57. doi: 10.2337/db10-0253. Epub 2010 Sep 28.

37.

Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss.

Divoux A, Tordjman J, Lacasa D, Veyrie N, Hugol D, Aissat A, Basdevant A, Guerre-Millo M, Poitou C, Zucker JD, Bedossa P, Clément K.

Diabetes. 2010 Nov;59(11):2817-25. doi: 10.2337/db10-0585. Epub 2010 Aug 16.

38.

Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.

Roubert P, Dubern B, Plas P, Lubrano-Berthelier C, Alihi R, Auger F, Deoliveira DB, Dong JZ, Basdevant A, Thurieau C, Clément K.

J Endocrinol. 2010 Nov;207(2):177-83. doi: 10.1677/JOE-09-0336. Epub 2010 Aug 9.

PMID:
20696697
39.

[Obesity, a disease].

Basdevant A, Ciangura C.

Bull Acad Natl Med. 2010 Jan;194(1):13-20; discussion 20-4. Review. French.

PMID:
20669556
40.

[Obesity medicine].

Basdevant A.

Presse Med. 2010 Sep;39(9):900-1. doi: 10.1016/j.lpm.2010.05.016. Epub 2010 Jul 21. French. No abstract available.

PMID:
20663634
41.

Latent variables and structural equation models for longitudinal relationships: an illustration in nutritional epidemiology.

Chavance M, Escolano S, Romon M, Basdevant A, de Lauzon-Guillain B, Charles MA.

BMC Med Res Methodol. 2010 Apr 30;10:37. doi: 10.1186/1471-2288-10-37.

42.

Evolution of obesity prevalence in France: an age-period-cohort analysis.

Diouf I, Charles MA, Ducimetière P, Basdevant A, Eschwege E, Heude B.

Epidemiology. 2010 May;21(3):360-5. doi: 10.1097/EDE.0b013e3181d5bff5.

43.

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.

Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J, Clément K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2892-6. doi: 10.1210/jc.2009-2374. Epub 2010 Apr 7.

PMID:
20375212
44.

Bariatric surgery in young massively obese diabetic patients.

Ciangura C, Basdevant A.

Diabetes Metab. 2009 Dec;35(6 Pt 2):532-6. doi: 10.1016/S1262-3636(09)73462-7. Review.

PMID:
20152740
45.

[New insights into obesity].

Basdevant A, Ciangura C.

Bull Acad Natl Med. 2009 Jun;193(6):1259-68; discussion 1268-9. French.

PMID:
20120157
46.

Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss.

Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A, Aissat A, Guerre-Millo M, Clément K.

J Clin Endocrinol Metab. 2009 Nov;94(11):4619-23. doi: 10.1210/jc.2009-0925. Epub 2009 Oct 16.

PMID:
19837929
47.

Dynamics of change in total and regional body composition after gastric bypass in obese patients.

Ciangura C, Bouillot JL, Lloret-Linares C, Poitou C, Veyrie N, Basdevant A, Oppert JM.

Obesity (Silver Spring). 2010 Apr;18(4):760-5. doi: 10.1038/oby.2009.348. Epub 2009 Oct 15.

48.

Pharmacology of morphine in obese patients: clinical implications.

Lloret Linares C, Declèves X, Oppert JM, Basdevant A, Clement K, Bardin C, Scherrmann JM, Lepine JP, Bergmann JF, Mouly S.

Clin Pharmacokinet. 2009;48(10):635-51. doi: 10.2165/11317150-000000000-00000. Review.

PMID:
19743886
49.

Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status.

Tordjman J, Poitou C, Hugol D, Bouillot JL, Basdevant A, Bedossa P, Guerre-Millo M, Clement K.

J Hepatol. 2009 Aug;51(2):354-62. doi: 10.1016/j.jhep.2009.02.031. Epub 2009 Apr 24.

PMID:
19464069
50.

Weight of pericardial fat on coronaropathy.

Clément K, Basdevant A, Dutour A.

Arterioscler Thromb Vasc Biol. 2009 May;29(5):615-6. doi: 10.1161/ATVBAHA.108.182907. No abstract available.

PMID:
19369652

Supplemental Content

Loading ...
Support Center